enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Why Is Regeneron Pharmaceuticals Stock Trading Lower Today? - AOL

   www.aol.com/why-regeneron-pharmaceuticals-stock...

   On Thursday, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) reported third-quarter adjusted EPS of $12.46, up 8% year-over-year, beating the consensus of $11.69. The company reported sales of $3.72 ...

3. What's Going On With Regeneron Pharmaceuticals Stock On ... - AOL

   www.aol.com/finance/whats-going-regeneron...

   On Friday, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion recommending ...

4. Regeneron preliminary Q4 US sales of Eylea below expectations

   www.aol.com/news/regeneron-preliminary-q4-us...

   Shares of Regeneron were down over 2% in premarket trading. Eylea, jointly developed with Bayer AG, has driven Regeneron's earnings for years, but sales have now come under pressure, partly from ...

5. Regeneron stock surges on positive results in eye disease ...

   www.aol.com/news/regeneron-stock-surges-positive...

   Regeneron stock surges on positive results in eye disease drug trial. September 8, 2022 at 12:57 PM ...

6. Is Regeneron Pharmaceuticals Inc (REGN) A Good Stock To Buy?

   www.aol.com/news/regeneron-pharmaceuticals-inc...

   For premium support please call: 800-290-4726 more ways to reach us

7. Regeneron (REGN) Stock Moves -0.8%: What You Should Know - AOL

   www.aol.com/news/regeneron-regn-stock-moves-0...

   Regeneron (REGN) closed at $615.88 in the latest trading session, marking a -0.8% move from the prior day. Skip to main content. 24/7 Help. For premium support please call: 800-290-4726 ...

8. Why Regeneron Pharmaceuticals (REGN) Isn't Done Growing ... - AOL

   www.aol.com/news/why-regeneron-pharmaceuticals...

   For premium support please call: 800-290-4726 more ways to reach us

9. Regeneron beats quarterly results on strong demand for ... - AOL

   www.aol.com/news/regeneron-beats-quarterly...

   Regeneron reported an adjusted profit of $11.56 per share on total revenue of $3.55 billion for the quarter, above analysts' estimates of $10.61 per share and $3.38 billion, according to LSEG data.